RecruitingPhase not listedNCT06433752
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Sponsor: TG Therapeutics, Inc.
Fresno, CA · Newport Beach, CA · Orange, CA · +106 more sites